Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Gold
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Olive View-University of California Los Angeles Medical Center
Sylmar, California, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Saint Louis University Hospital
St Louis, Missouri, United States
- Sunrise Hospital and Medical Center
Las Vegas, Nevada, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
- Summa Akron City Hospital/cooper Cancer Center
Akron, Ohio, United States
- University of Cincinnati/barrett Cancer Center
Cincinnati, Ohio, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
- Lake University Ireland Cancer Center
Mentor, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Apr 2007
- Primary completion
- 16 Jul 2016
- Completion
- 16 Jul 2016
- Last update posted
- 24 Aug 2017
- Registered enrollment
- 159
- Registry id
- NCT00460356
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.